Roderick de Greef Biography and Net Worth
Roderick (Rod) de Greef has served as BioLife’s Chief Financial Officer since May of 2016. He was additionally appointed Chief Operating Officer in December 2019. Rod has a longstanding association with BioLife, having served as a director of the company from June 2000 through November 2013 and provided the company with strategic and financial consulting services from July 2007 through August 2011.
Due to his extensive experience in business and corporate finance, Rod is in high demand as an officer and director of public companies. He has served as a director and chairman of the Audit Committee of the Board of Directors of Indonesia Energy Corporation Limited since February 2019. Rod has twice served the mobile communications company Pareteum Corporation (2008-2011 and 2015-2017), as a director, Chair of the Audit Committee, and a member of the Nominating and Corporate Governance Committee and the Compensation Committee. Rod was Chairman of the Board at Cambridge Heart, Inc. from November 2008 to October 2013 and went on to serve as President and sole Director of that company’s privately held successor, Cambridge Cardiac Technologies, from November 2013 to October 2014. He served as a director, member of the audit committee and chairman of the compensation committee for Endologix, Inc. from November 2003 to May 2013. From 2001 to 2006, Rod was Executive Vice President and Chief Financial Officer of NASDAQ-listed Cardiac Science, Inc.
Rod has an MBA from the University of Oregon, and a B.A in Economics and International Relations from San Francisco State University.
What is Roderick de Greef's net worth?
The estimated net worth of Roderick de Greef is at least $1.37 million as of November 28th, 2022. Mr. de Greef owns 69,719 shares of BioLife Solutions stock worth more than $1,370,676 as of December 9th. This net worth estimate does not reflect any other investments that Mr. de Greef may own. Learn More about Roderick de Greef's net worth.
What is Roderick de Greef's salary?
As the CFO of BioLife Solutions, Inc., Mr. de Greef earned a total compensation package of $1,180,590.00 in 2021. Mr. de Greef earned a salary of $412,137.00, a bonus of $223,850.00, stock awards of $544,603.00, and no other miscellaneous compensation. Learn More on Roderick de Greef's salary.
How do I contact Roderick de Greef?
Has Roderick de Greef been buying or selling shares of BioLife Solutions?
In the last ninety days, Roderick de Greef has sold $1,978,803.18 in shares of BioLife Solutions stock. Most recently, Greef Roderick De sold 33,905 shares of the business's stock in a transaction on Wednesday, November 30th. The shares were sold at an average price of $20.59, for a transaction totalling $698,103.95. Following the completion of the sale, the chief operating officer now directly owns 34,314 shares of the company's stock, valued at $706,525.26. Learn More on Roderick de Greef's trading history.
Who are BioLife Solutions' active insiders?
Are insiders buying or selling shares of BioLife Solutions?
In the last twelve months, insiders at the medical equipment provider sold shares 104 times. They sold a total of 415,981 shares worth more than $10,027,494.49. The most recent insider tranaction occured on November, 30th when COO Greef Roderick De sold 33,905 shares worth more than $698,103.95. Insiders at BioLife Solutions own 3.3 % of the company. Learn More about insider trades at BioLife Solutions.
Information on this page was last updated on 11/30/2022.
Roderick de Greef Insider Trading History at BioLife Solutions
|Transaction Date||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
BioLife Solutions Company Overview
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
50 Day Range
2 Week Range